Market
Inhibrx Inc [INBX] moved down -0.54: Why It’s Important
Inhibrx Inc [NASDAQ: INBX] closed the trading session at $34.96. The company report on February 28, 2024 at 9:15 AM that Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results. Inhibrx, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a biopharmaceutical company with three clinical
